Charme Capital Partners Acquires Majority Stake in Bianalisi

Charme Capital Partners Acquires 56% Stake in Animalia

July 3, 2024

Veterinary

Charme Capital Partners (via its Charme IV fund) has agreed to take a 56% stake in Animalia through a capital increase, partnering with founders Antonino Santalucia and Giorgio Romani who will remain co-CEOs and minority shareholders. The investment will fund Animalia's consolidation and organic growth plan—including targeted add‑ons and expansion of clinic services—across its network of more than 75 clinics in Italy.

Charme Capital Partners Acquires Majority Stake in Tema Sinergie

October 27, 2022

Medical Devices

Charme Capital Partners (through its Charme IV fund) will acquire a majority stake in Tema Sinergie S.p.A., an Italian manufacturer of isolators and filling/inspection systems for nuclear medicine and biotech pharmaceutical production. The investment will support Tema Sinergie's international expansion, product innovation and growth in theragnostic and biotech segments while preserving management continuity under CEO Stefano Piancastelli.

Charme Capital Partners Acquires Prism Healthcare

March 1, 2022

Medical Devices

Charme Capital Partners’ Charme IV fund has acquired Prism Healthcare, a UK-based manufacturer and provider of specialist patient handling and care equipment. Limerston Capital will remain invested alongside the management team; Charme’s investment will support Prism’s organic growth, international expansion and continued buy-and-build strategy.

Charme Capital Partners Acquires Bright Futures Care

June 22, 2023

Healthcare Services

Charme Capital Partners (Charme IV) has acquired Bright Futures Care, a specialist provider of education and residential care for people with autism and learning disabilities across the North-West of England. Livingbridge has retained a minority stake; terms were not disclosed and Charme said the investment will support further organic growth and geographic expansion across the UK.

Charme Capital Partners and Miura Capital Acquire INDIBA from Magnum

February 28, 2022

Medical Devices

Private equity firms Charme Capital Partners and Miura Capital have completed the acquisition of INDIBA, a Barcelona-based developer of 448 kHz radio-frequency medical devices for physiotherapy, aesthetics and veterinary markets, from Magnum. The deal positions INDIBA for a next phase of growth, with plans to expand market reach, product portfolio and operations under the new ownership.

Great Point Partners Acquires Majority Stake in Lenis Group

December 16, 2025

Healthcare Services

Great Point Partners has acquired a majority stake in Lenis Group, a Ljubljana-based full-service commercialization and distribution partner for niche and specialty prescription medicines across Central and Eastern Europe. The investment will support Lenis's regional expansion, strengthen senior leadership (including appointment of former Biogen CEO Michel Vounatsos as board chairman), and deepen its capabilities in market access, regulatory, medical and distribution services.